86 related articles for article (PubMed ID: 29286487)
1. Using the Dot Assay to Analyze Migration of Cell Sheets.
Stuelten CH
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286487
[TBL] [Abstract][Full Text] [Related]
2. Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.
Weiger MC; Vedham V; Stuelten CH; Shou K; Herrera M; Sato M; Losert W; Parent CA
PLoS One; 2013; 8(3):e58859. PubMed ID: 23527039
[TBL] [Abstract][Full Text] [Related]
3. Determination of Breast Cancer Cell Migratory Ability.
Schmitt D; Andrews J; Tan M
Methods Mol Biol; 2016; 1406():171-80. PubMed ID: 26820954
[TBL] [Abstract][Full Text] [Related]
4. Effect of aluminium on migratory and invasive properties of MCF-7 human breast cancer cells in culture.
Darbre PD; Bakir A; Iskakova E
J Inorg Biochem; 2013 Nov; 128():245-9. PubMed ID: 23896199
[TBL] [Abstract][Full Text] [Related]
5. Measuring cell motility using quantum dot probes.
Gu W; Pellegrino T; Parak WJ; Boudreau R; Le Gros MA; Alivisatos AP; Larabell CA
Methods Mol Biol; 2007; 374():125-31. PubMed ID: 17237535
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cell migration within a three-dimensional collagen matrix.
Rommerswinkel N; Niggemann B; Keil S; Zänker KS; Dittmar T
J Vis Exp; 2014 Oct; (92):e51963. PubMed ID: 25350138
[TBL] [Abstract][Full Text] [Related]
7. Time-lapse lens-free imaging of cell migration in diverse physical microenvironments.
Mathieu E; Paul CD; Stahl R; Vanmeerbeeck G; Reumers V; Liu C; Konstantopoulos K; Lagae L
Lab Chip; 2016 Aug; 16(17):3304-16. PubMed ID: 27436197
[TBL] [Abstract][Full Text] [Related]
8. Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.
Bessette DC; Tilch E; Seidens T; Quinn MC; Wiegmans AP; Shi W; Cocciardi S; McCart-Reed A; Saunus JM; Simpson PT; Grimmond SM; Lakhani SR; Khanna KK; Waddell N; Al-Ejeh F; Chenevix-Trench G
PLoS One; 2015; 10(5):e0125232. PubMed ID: 25969993
[TBL] [Abstract][Full Text] [Related]
9. A Novel Collagen Dot Assay for Monitoring Cancer Cell Migration.
Alford VM; Roth E; Zhang Q; Cao J
Methods Mol Biol; 2016; 1406():181-7. PubMed ID: 26820955
[TBL] [Abstract][Full Text] [Related]
10. Bioengineering embryonic stem cell microenvironments for exploring inhibitory effects on metastatic breast cancer cells.
Raof NA; Raja WK; Castracane J; Xie Y
Biomaterials; 2011 Jun; 32(17):4130-9. PubMed ID: 21411140
[TBL] [Abstract][Full Text] [Related]
11. Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber.
Haessler U; Teo JC; Foretay D; Renaud P; Swartz MA
Integr Biol (Camb); 2012 Apr; 4(4):401-9. PubMed ID: 22143066
[TBL] [Abstract][Full Text] [Related]
12. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy.
Jung KH; Choe YS; Paik JY; Lee KH
J Nucl Med; 2011 Sep; 52(9):1457-64. PubMed ID: 21849406
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Influence of a Protease in Cell Migration Using the Barrier-Migration Assay.
Fontanil T; Mohamedi Y; Cal S; Obaya ÁJ
Methods Mol Biol; 2018; 1731():133-143. PubMed ID: 29318550
[TBL] [Abstract][Full Text] [Related]
15. Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.
Pignatelli J; Goswami S; Jones JG; Rohan TE; Pieri E; Chen X; Adler E; Cox D; Maleki S; Bresnick A; Gertler FB; Condeelis JS; Oktay MH
Sci Signal; 2014 Nov; 7(353):ra112. PubMed ID: 25429076
[TBL] [Abstract][Full Text] [Related]
16. Scratch-wound assay.
Cory G
Methods Mol Biol; 2011; 769():25-30. PubMed ID: 21748666
[TBL] [Abstract][Full Text] [Related]
17. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
[TBL] [Abstract][Full Text] [Related]
18. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
19. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
20. Effects of exposure to six chemical ultraviolet filters commonly used in personal care products on motility of MCF-7 and MDA-MB-231 human breast cancer cells in vitro.
Alamer M; Darbre PD
J Appl Toxicol; 2018 Feb; 38(2):148-159. PubMed ID: 28990245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
